Block 6 drugs Flashcards
Zafirlukast, Montelukast: indication, MOA and adverse effects
Leukotriene inhibitor used for Prophylactic therapy for preventing bronchospasm MOA: Antagonist of LTD4 and LTE4 leukotriene receptors. Can cause Headache, nausea
Voriconazole indication, MOA and adverse effects
dermatophytes, candida, C. glabrata and C. krusei, cryptococcus, cocci/histo/blasto, pseudoallerischeri boydii, aspergillus, and fusarium MOA: Inhibition of ergosterol synthesis
Can have adverse effects: Photosensitivity, rash, periostitis, visual changes, hallucinations, seizures. DOC for invasive aspergillus/fusarium
What is the indication and MOA for Mycophenolate mofetil therapy?
Proliferation inhibitor used to Prevent graft rejection, off label used for autoimmune diseases (Pemphigus, SLE, myasthenia gravis, psoriasis). MOA: Reversible inhibitor of IMPDH type II, the rate limiting enzyme in de novo purine synthesis
Fexofenadine: indication, MOA and adverse effects
2nd generation antihistamine used for Allergic rhinitis, idiopathic chronic uticaria MOA: Blocks histamine H1 receptors. Can cause N/A
Terbinafine indication, MOA and adverse effects
Onchomycoses and superficial skin infections of candida albicans, dermatophytes MOA: Inhibits fungal squalene epoxidase resulting in formation of toxic products and inhibition of ergosterol synthesis
Adverse effects: generally well tolerated, but can cause hepatotoxicity, neutropenia, Stevens-Johnson syndrome.
What is the indication and MOA for Alemetzumab therapy?
Antibody used to Acutely inhibit T cell response at time of transplantation. MOA: Anti-CD52 causes antibody mediates lysis of lyphocytes
Loratidine: indication, MOA and adverse effects
2nd generation antihistamine used for Allergic rhinitis, allergic reactions to blood, adjunctive therapy in anaphylactic reactions MOA: Blocks histamine H1 receptors. Can cause Nausea, fatigue, headache
What is the indication and MOA for Iron therapy?
Iron therapy is used for patients with Increased iron requirements: premature infants, children, pregnant/lactating women; inadequate absorption; blood loss. Given orally or IM/IV to supplement missing Fe.
What is the indication and MOA for Fingolimod therapy?
MS drug used to Replasing-remitting multiple sclerosis. MOA: Sphingosine analog, sequesters lymphocytes in lymph node, preventing access to the CNS
What is the indication and MOA for Vitamin B12 therapy?
Vitamin B12 therapy is used for patients with Vitamin B12 deficiency (can have CNS deficiency). Parenteral injection of cyanocobalamin or hydroxycobalamin. Complexes with IF in the stomach and gets absorbed in the ileum
What is the indication and MOA for Erythropoietin therapy?
Erythropoietin therapy is used for patients with Chronic renal failure, aplastic anemia, leukemias, HIV, anemia of prematurity, post-phlebotomy. IV or SubQ injections stimulate release of reticulocytes from bone marrow, proliferation, differentiation of RBCs
Amphotericin B indication, MOA and adverse effects
Broad spectrum, covers all life threatening mycotic infections MOA: Binds to ergosterol in fungal plasma membrane forming pores that increases membrane permeability and permits loss of cytoplasmic K+
Can have adverse effects: Infusion related: fever, chills, spasms, vomiting. Also causes cumulative nephrotoxicity, hepatotoxicity and anemia. “Amphoterrible”. Only antifungal used in pregnant women
What is the indication and MOA for Cyclosporin therapy?
Calcineurin inhibitor used to Prevent solid organ rejection, GvH disease in BMT, autoimmune diseases (psoriasis, rheumatoid arthritis, SLE, IBD). MOA: Binds to cyclophilin, inhibits the activity of calcineurin, which prevents T cell activation by NFAT, IL2. Inhibits “signal 1” of T cell activation
What is the indication and MOA for Everolimus therapy?
mTor inhibitor used to Prevent graft rejection (not for liver, lungs), prevent GvH disease in BMT, included in coronary stents to prevent restenosis. MOA: Binds to FKBP, inhibits mTOR kinase, which prevents IL-2 mediated signals in T-cells “signal 2”, no T cell proliferation
What is the indication and MOA for Natalizumab therapy?
MS drug used to Replasing-remitting multiple sclerosis. MOA: Anti-alpha4 integrin blocks entry of lymphocytes into the CNS
What is the indication and MOA for Iplimumab therapy?
Immune checkpoint inhibitor used to Late stage melanomas (also clinical trials for NSCLC, SCLC, prostate cancer, bladder cancer). MOA: anti-CTLA4 antibody, prevents CTLA4 from delivering negative signal , leading to enhanced T-cell activation
What is the indication and MOA for IVIG therapy?
Passive immunization Ig used to Hypogammaglobulinemia and other immunodeficiency diseases.. MOA: Supplement Ig’s purified from pooled human plasma
What is the indication and MOA for Nivolumab therapy?
Immune checkpoint inhibitor used to Metastatic melanoma. MOA: anti-PD1 blocks PD1-PD-L1 interaction leading to enhanced T cell immune responses
Theophyline: indication, MOA and adverse effects
Bronchodilator used for Chronic asthma maintenance therapy MOA: Inhibits cAMP phosphodiesterases causing increased levels of cAMP. Narrow therapeutic window, convulsions, tachycardia, circulatory collapse
What is the indication and MOA for Pembrozilmab therapy?
Immune checkpoint inhibitor used to Metastatic melanoma. MOA: anti-PD1 blocks PD1-PD-L1 interaction leading to enhanced T cell immune responses
“PemDrozi1mab” PD1
Isoniazid HCl (INH) indication, MOA, and adverse effects
Indication: Tuberculosis first line drug, monotherapy for latent TB. MOA: Prodrug activated by catalase peroxidase (katG gene), targets the inhA gene product to prevent cell wall mycolic acid synthesis. Can cause Hepatotoxicity, neurotoxicity, hypersensitivity reaction.
Diphenhydramine: indication, MOA and adverse effects
1st generation antihistamine used for Allergic rhinitis, urticaria, and adjunctive therapy in anaphylactic reactions MOA: Blocks histamine H1 receptors. Can cause Sedation, agitation due to muscarinic receptor blockade
Beta 2 adrenergic agonists: indication, MOA and adverse effects
Bronchodilator used for Symptom relief of bronchospasm in acute asthma attacks MOA: Stimulate AC increasing cAMP, causes SM bronchodilation. Inhibits release of mediators from mast cells.. Can cause Skeletal muscle tremors, techycardia, anxiety/restlessness/apprehension